Skip to main content
Link to Walkers homepage
Back to News landing page

Walkers BVI Advises on the Completed US$11.6 billion Merger of Pfizer and Biohaven

Oct 10, 2022

Our work
A man in a business suit signing a legal contract.

Walkers is pleased to have acted as British Virgin Islands ("BVI") counsel to Pfizer Inc. (NYSE:PFE) on its US$11.6 billion cash acquisition of Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN), which closed on Monday 3 October.

The take-private transaction was implemented by way of a BVI statutory merger and represents the largest ever takeover of a publicly-listed BVI company by transaction value.

This transaction underscores Walkers' leading M&A practice in the BVI and its high-value cross border capabilities supported by its corporate services arm Walkers Corporate (BVI) Limited

Pursuant to the transaction, Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately $11.6 billion. As a result of the acquisition, Biohaven became a wholly-owned subsidiary of Pfizer. Effective immediately prior to the closing of the acquisition, Biohaven completed the spin-off of Biohaven Ltd, distributing Biohaven Ltd.’s shares to Biohaven’s shareholders. Pfizer, a Biohaven shareholder, received a pro rata portion of Biohaven Ltd.’s shares in the distribution and owns approximately 3% of Biohaven Ltd. Biohaven Ltd. will continue to trade on the New York Stock Exchange under the ticker (NYSE: BHVN).

Commenting on the transaction, BVI Managing Partner Matthew Cowman said, "We are delighted to have worked alongside Ropes & Gray on such an important transaction for Pfizer. Transactions like this demonstrate Walkers' credentials as the go-to firm in the BVI for high-value cross border M&A and once again highlights the attractiveness of the BVI as a jurisdiction that can facilitate complex cross-border M&A deals for our global listed clients".

The Walkers team, comprising Matthew Cowman, Alex Drysdale, Rosalind Nicholson, Syed Islam and McKay Andrew, advised Pfizer on the transaction in concert with US counsel Ropes & Gray.
Corporate, Mergers & AcquisitionsBritish Virgin Islands

MEDIA CONTACT

Emily Hirsch

Communications and Digital Marketing Manager - Americas/Cayman Islands

T/+1 345 814 6805
M/+1 345 936 6805
E/Email Emily Hirsch

Solution area

Corporate, Mergers & Acquisitions

KEY CONTACTS

Get in touch with our team

//
Matthew Cowman
Matthew Cowman

Matthew Cowman

Managing Partner

British Virgin Islands

T

+1 284 852 2208

M

+1 284 542 2208

E

Email Matthew Cowman
View profile
Alex Drysdale
Alex Drysdale

Alex Drysdale

Partner

British Virgin Islands

T

+1 284 852 2262

M

+1 284 542 2262

E

Email Alex Drysdale
View profile
Rosalind Nicholson
Rosalind Nicholson

Rosalind Nicholson

Partner

British Virgin Islands

T

+1 284 852 2237

M

+1 284 542 2237

E

Email Rosalind Nicholson
View profile
McKay Drigo
McKay Drigo

McKay Drigo

Associate

British Virgin Islands

T

+1 284 852 2254

M

+1 284 542 2254

E

Email McKay Drigo
View profile
Syed Islam

Syed Islam

Associate

Singapore

T

+65 6603 1646

M

+65 8870 6881

E

Email Syed Islam
View profile

Get the latest insights and expertise in your inbox 

Fluid ink image
Sign up
logo footer

Connect with us

FacebookFacebook
InstagramInstagram
LinkedInLinkedIn

Employee login

Self Service Password ResetWalkers AnywhereWalkers Sharefile
Legal notices/Cookies policy

All rights reserved - © 2025 Walkers Global